Bicara Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jun '25 Jun 27, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	475	948	-	-
Enterprise Value	14	428	-	-
Last Close Price	9.43	17.42	-	-
Debt / Equity Ratio	0.00	0.00	0.00	-
Quick Ratio	24.17	27.22	15.28	0.17
Current Ratio	24.62	27.93	15.32	0.21
Return on Equity (ROE)	-27.26%	-19.14%	-51.67%	-
Return on Assets (ROA)	-	-13.84%	-20.72%	-
Return on Capital (ROIC)	-20.04%	-14.47%	-24.70%	-
Buyback Yield / Dilution	-4870.87%	-2796.96%	-35.20%	-

Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q